Financials
Financial year 2025
LION BOURLARD MEDICAL from Le Roeulx, company number BE0847087439, closed financial year 2025 with a result of € 62,185 after tax. For that financial year LION BOURLARD MEDICAL recorded a gross margin of € 172,912 and equity of € 460,124. Compared with financial year 2024, the result moved from € 99,653 to € 62,185. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 7, 2026.
€ 460,124
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 62,185
▼ 38% vs 2024
Profit after tax over the fiscal year.
€ 121,364
▲ 13% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 21,000 paid out
34 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 38,996
▼ 36% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 393,524
▼ 12% vs 2024
€ 45,991 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 3,018
▲ 33% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,763
▼ 76% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 161,153 | € 161,133 | € 212,588 | € 172,912 | ▼ 19% |
| Profit after taxes | € 79,081 | € 68,439 | € 99,653 | € 62,185 | ▼ 38% |
| Equity | € 269,847 | € 338,286 | € 418,939 | € 460,124 | ▲ 10% |
| Total debts | € 416,176 | € 537,792 | € 489,665 | € 406,305 | ▼ 17% |
| Cash | € 88,552 | € 68,112 | € 107,855 | € 121,364 | ▲ 13% |
| Land & buildings | € 393,560 | € 514,072 | € 490,631 | € 432,525 | ▼ 12% |
| Retained profit | € 263,647 | € 332,086 | € 412,739 | € 453,924 | ▲ 10% |
| Dividend | € 22,000 | € 0 | € 19,000 | € 21,000 | ▲ 11% |
| Bank debt | € 392,898 | € 497,246 | € 445,853 | € 393,524 | ▼ 12% |
| Balance sheet total | € 686,022 | € 876,078 | € 908,604 | € 866,429 | ▼ 5% |
Key figures of LION BOURLARD MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LION BOURLARD MEDICAL?
What happened at LION BOURLARD MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 62,185 (▼ 38% vs 2024). filed late Source: NBB ↗
- New establishment in Le Roeulx. KBO
- New establishment in Le Roeulx. KBO
- Start of the company according to the CBE. KBO
In short
From € 79,081 profit in 2022 to € 62,185 profit in 2025.
Paid € 125,958 in corporate taxes since 2022.
Best year ever: 2024, with € 99,653 profit.
Paid out € 62,000 in dividends to the owners in total.
Management
Behind LION BOURLARD MEDICAL are Christophe Bourlard and Christelle Lion.
Directors
According to the 2025 annual accounts
Christophe Bourlard
Director
Christelle Lion
Director
Establishments
Establishment units
Physical locations of this company
Rue Mont Coupé(GOT) 47
7070 Le Roeulx
Place du Château(R) 7
7070 Le Roeulx
Active since 3 July 2012
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0847.087.439
- VAT number
- BE 0847.087.439
- Registered office
- Rue Mont Coupé(GOT) 47, 7070 Le Roeulx
- Names & denominations
- LION BOURLARD MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 July 2012
- Peppol
- Active · Active since 9 Dec 2025
- Activities · NACE
Activiteiten van huisartspraktijken